Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis

Brain and Development

Volumn 37, Issue 1, 2015, Pages 145-148

  Tsuburaya, Rie S ^a   Miki, Naoki ^b   Tanaka, Keiko ^c   Kageyama, Takashi ^b   Irahara, Kaori ^a   Mukaida, Souichi ^a   Shiraishi, Kazuhiro ^a   Tanaka, Masami ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b TENRI HOSPITAL   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute disseminated encephalomyelitis; Multiple sclerosis; Myelin oligodendrocyte glycoprotein (MOG); Neuromyelitis optica; Optic neuritis

Indexed keywords

ANTIBODY; BETA1A INTERFERON; CARBAMAZEPINE; INTERFERON BETA SERINE; MESSENGER RNA; METHYLPREDNISOLONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PREDNISOLONE; RECOMBINANT BETA INTERFERON; UNCLASSIFIED DRUG; AUTOANTIBODY; AUTOANTIGEN; MOG PROTEIN, HUMAN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ARTICLE; CASE REPORT; CHILD; CRITICAL FLICKER FUSION; HUMAN; IMMUNOASSAY; MALE; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY; OPTIC NEURITIS; PLASMAPHERESIS; RECURRENT DISEASE; SCHOOL CHILD; SEIZURE; VISUAL ACUITY; WHITE MATTER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; IMMUNOLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; AUTOANTIGENS; CHILD; HUMANS; MALE; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OPTIC NEURITIS; RECURRENCE;

EID: 84919430246     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2014.02.002     Document Type: Article

References (8)

1. Brunner C., Lassmann H., Waehneldt T.V., Matthieu J.M., Linington C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem 1989, 52:296-304.
2. Reindl M., Di Pauli F., Rostásy K., Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013, 9:455-461.
3. Kitley J., Woodhall M., Waters P., Leite M.I., Devenney E., Craig J., et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 2012, 18:1273-1277.
4. Mader S., Gredler V., Schanda K., Rostasy K., Dujmovic I., Pfaller K., et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 2011, 8:184.
5. Rostasy K., Mader S., Schanda K., Huppke P., Gärtner J., Kraus V., et al. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 2012, 69:752-756.
6. Rostásy K., Mader S., Hennes E.M., Schanda K., Gredler V., Guenther A., et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 2013, 19:1052-1059.
7. Huppke P., Rostasy K., Karenfort M., Huppke B., Seidl R., Leiz S., et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler 2013, 19:941-946.
8. Krupp L.B., Tardieu M., Amato M.P., Banwell B., Chitnis T., Dale R.C., et al. International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013, 19:1261-1267.